205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-12.77%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-14.16%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-21.48%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-21.73%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-21.08%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-19.88%
Negative EPS growth while ON is at 2.56%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-19.62%
Negative diluted EPS growth while ON is at 2.63%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.65%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.92%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
24.31%
Dividend growth of 24.31% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
1.85%
OCF growth under 50% of ON's 17.53%. Michael Burry might suspect questionable revenue recognition or rising costs.
4.95%
FCF growth under 50% of ON's 24.88%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
100.57%
10Y revenue/share CAGR at 50-75% of ON's 198.64%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
39.89%
5Y revenue/share CAGR under 50% of ON's 122.20%. Michael Burry would suspect a significant competitive gap or product weakness.
23.68%
3Y revenue/share CAGR under 50% of ON's 76.99%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
157.89%
10Y OCF/share CAGR under 50% of ON's 403.42%. Michael Burry would worry about a persistent underperformance in cash creation.
103.87%
Below 50% of ON's 251.85%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
59.17%
3Y OCF/share CAGR under 50% of ON's 164.99%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
1456.48%
Net income/share CAGR above 1.5x ON's 131.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
176.30%
5Y net income/share CAGR at 50-75% of ON's 319.50%. Martin Whitman might see a shortfall in operational efficiency or brand power.
57.27%
Below 50% of ON's 202.87%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
29.63%
Below 50% of ON's 353.74%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-5.16%
Negative 5Y equity/share growth while ON is at 129.44%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-4.04%
Negative 3Y equity/share growth while ON is at 95.13%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
601.64%
Stable or rising dividend while ON is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
157.27%
Dividend/share CAGR of 157.27% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
102.33%
3Y dividend/share CAGR of 102.33% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-23.85%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
4.77%
Inventory growth well above ON's 2.05%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-7.73%
Negative asset growth while ON invests at 2.40%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-13.04%
We have a declining book value while ON shows 1.77%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
0.02%
Debt shrinking faster vs. ON's 1.89%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
2.56%
We increase R&D while ON cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
4.55%
SG&A growth well above ON's 0.13%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.